Pivotal

Pivotal China is a venture capital firm with early-stage activity across life sciences and health-related markets, including biotechnology, oncology, pharmaceuticals and women’s health. It has acted as a co-lead investor in a Series A financing and has United States and China investment exposure. Its investment mandate also includes companies addressing caregiving, women’s economic power and financial access, as well as commitments to emerging fund managers.